Sarilumab (Kevzara) Approved in EU for Rheumatoid Arthritis

Sarilumab (Kevzara) Approved in EU for Rheumatoid ArthritisSarilumab is indicated for adults with moderate to severe active rheumatoid arthritis who fail or are intolerant to disease-modifying antirheumatic drugs.
International ApprovalsSarilumab is indicated for adults with moderate to severe active rheumatoid arthritis who fail or are intolerant to disease-modifying antirheumatic drugs.
International Approvals
Go to Source
Author:

Powered by WPeMatico